GENZYME CORP 4

Accession 0001225208-11-011389

CIK 0000732485operating

View on SEC.gov Company Profile

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 2:06 PM ET

Size

90.9 KB

Accession

0001225208-11-011389

Insider Transaction Report

Form 4

Period: 2011-04-04

GENZYME CORPGENZ

MCGILLICUDY CORNELIUS III

Director

Transactions

Disposition to Issuer
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−2,375$175,750→ 10,905.419 total
Exercise/Conversion
Phantom Stock
2011-04-04−230.701→ 0 total
From: 2002-06-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (230.701 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−252.283→ 0 total
From: 2004-06-30Exp: 2026-12-30→ Genzyme common stock (GENZ) (252.283 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−192.176→ 0 total
From: 2005-06-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (192.176 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−191.131→ 0 total
From: 2007-06-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (191.131 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−227.263→ 0 total
From: 2004-09-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (227.263 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−161.61→ 0 total
From: 2005-09-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (161.61 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−253.857→ 0 total
From: 2007-09-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (253.857 underlying)
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+2,375→ 7,375 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+1,833.391→ 9,208.391 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+327.267→ 9,535.658 total
Exercise/Conversion
Phantom Stock
2011-04-04−327.267→ 0 total
From: 2004-03-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (327.267 underlying)
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+253.857→ 11,189.842 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+227.263→ 12,370.989 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+201.241→ 12,572.23 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+161.61→ 13,280.419 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+292.961→ 10,144.965 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+278.649→ 10,423.614 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+252.283→ 11,442.125 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+192.176→ 12,764.406 total
Disposition from Tender
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−5,000$370,000→ 5,905.419 total
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$58.66/sh−7,500$439,950→ 0 total
Exercise: $58.66From: 2010-05-21Exp: 2019-05-21→ Genzyme common stock (GENZ) (7,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$58.50/sh−15,000$877,500→ 0 total
Exercise: $58.50From: 2007-05-25Exp: 2016-05-26→ Genzyme common stock (GENZ) (15,000 underlying)
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+254.06→ 10,935.985 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+237.499→ 11,679.624 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+233.401→ 11,913.025 total
Disposition to Issuer
Genzyme common stock (GENZ)
2011-04-04$76.01/sh−5,905.419$448,871→ 0 total
Exercise/Conversion
Phantom Stock
2011-04-04−278.649→ 0 total
From: 2007-03-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (278.649 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−201.241→ 0 total
From: 2006-06-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (201.241 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−292.961→ 0 total
From: 2006-12-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (292.961 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−316.346→ 0 total
From: 2007-12-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (316.346 underlying)
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$46.24/sh−9,000$416,160→ 0 total
Exercise: $46.24Exp: 2013-05-29→ Genzyme common stock (GENZ) (9,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$68.48/sh−7,500$513,600→ 0 total
Exercise: $68.48From: 2009-05-22Exp: 2018-05-22→ Genzyme common stock (GENZ) (7,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$62.98/sh−24,000$1,511,520→ 0 total
Exercise: $62.98From: 2006-05-26Exp: 2015-05-26→ Genzyme common stock (GENZ) (24,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$53.47/sh−4,000$213,880→ 0 total
Exercise: $53.47From: 2002-05-31Exp: 2011-05-31→ Genzyme common stock (GENZ) (4,000 underlying)
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+230.701→ 12,143.726 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+191.131→ 12,955.537 total
Exercise/Conversion
Phantom Stock
2011-04-04−237.499→ 0 total
From: 2005-03-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (237.499 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−254.06→ 0 total
From: 2006-03-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (254.06 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−163.272→ 0 total
From: 2006-09-30Exp: 2026-12-31→ Genzyme common stock (GENZ) (163.272 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−1,833.391→ 0 total
From: 2003-12-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (1,833.391 underlying)
Exercise/Conversion
Phantom Stock
2011-04-04−258.311→ 0 total
From: 2005-12-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (258.311 underlying)
Exercise/Conversion
Restricted Stock Units
2011-04-04−2,375→ 0 total
Exercise: $0.00→ Genzyme common stock (GENZ) (2,375 underlying)
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+316.346→ 9,852.004 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+258.311→ 10,681.925 total
Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+163.272→ 13,118.809 total
Exercise/Conversion
Phantom Stock
2011-04-04−233.401→ 0 total
From: 2004-12-31Exp: 2026-12-31→ Genzyme common stock (GENZ) (233.401 underlying)
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$51.52/sh−7,125$367,080→ 0 total
Exercise: $51.52Exp: 2020-06-16→ Genzyme common stock (GENZ) (7,125 underlying)
Disposition to Issuer
Stock Option (right to buy)
2011-04-04$62.16/sh−15,000$932,400→ 0 total
Exercise: $62.16From: 2008-05-24Exp: 2017-05-24→ Genzyme common stock (GENZ) (15,000 underlying)

Footnotes (3)

[F1]The phantom stock acquired under the Genzyme Directors? Deferred Compensation Plan was cancelled at the completion of the sanofi-aventis tender offer and converted into the right to receive a cash payment based on the closing price of Genzyme common stock on the last day it traded. Phantom stock was credited to the Reporting Person?s stock account under the deferred compensation at the end of each fiscal quarter from 1/1/2004 through 12/31/2007, pursuant to the Reporting Person?s plan election and the terms of the plan.
[F2]The vested restricted stock units were scheduled to vest on the date of the 2011 annual meeting of shareholders.
[F3]This option, which provided for vesting at the next annual meeting of shareholders, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.

Documents

1 file

4
doc4.xmlPrimary

Issuer

GENZYME CORP

CIK 0000732485

→

Entity typeoperating

IncorporatedMA

Related Parties

filerCIK 0000732485

Filing Metadata

Form type: 4
Filed: Apr 5, 8:00 PM ET
Accepted: Apr 6, 2:06 PM ET
Size: 90.9 KB

View on SEC.gov